| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| E-therapeutics Plc |
LSE:ETX |
London |
Ordinary Share |
GB00B2823H99 |
ORD 0.1P |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
-1.85 |
-8.87% |
19.00 |
382,883 |
10:38:13 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
19.05
|
20.90
|
21.90 |
18.95 |
21.90 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Pharmaceuticals & Biotechnology
|
0.46
|
-2.87
|
-0.87
|
|
80
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 13:17:56 |
O |
2,408 |
20.30 |
GBX |
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 12:17:57 | 20.30 | 2,408 | 488.82 | O |
| 12:13:25 | 20.44 | 58 | 11.85 | O |
| 09:49:59 | 20.40 | 10,000 | 2,040.00 | O |
| 09:38:13 | 19.00 | 191,430 | 36,371.70 | AT |
| 09:35:57 | 19.00 | 13,345 | 2,535.55 | AT |
| Date | Subject |
|---|
19/4/2021
09:20 | E-therapeutics Daily Update: E-therapeutics Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 20.85p.
E-therapeutics Plc has a 4 week average price of 18.95p and a 12 week average price of 18.20p.
The 1 year high share price is 26.80p while the 1 year low share price is currently 10.75p.
There are currently 420,740,129 shares in issue and the average daily traded volume is 1,437,492 shares. The market capitalisation of E-therapeutics Plc is £79,940,624.51.
|
15/3/2021
15:52 | dplewis1: It's all down to the condition codes. If the trades are LB (Central Limit Order Book) and ALGO, then the price moves to that level. Look at the trade at 09:59:10 at 22 as an example. If they are OB (Off Book) then the price does not move, hence the price has not changed to 23.8775 which was the last trade because it's an off book.
|
15/3/2021
14:01 | ali47fish: dpl thanks for the answer but i still do not understand i look at the price and it is down-please explain- anyway i just added a smidgen
|
05/2/2021
12:59 | toffeeman: >>dplewis1
I'll see your 2.5p for ETX and raise you 5.7p for SNG :):)
|
22/1/2021
17:20 | dplewis1: Only certain condition codes change the price, it was introduced in MiFID II. So the algo executions have a price adjusting condition code and that's what skewed the price away from the mid
|
08/1/2021
11:36 | dynoport: Just a thought, I wonder if ETX has been tipped anywhere, Techinvest perhaps?
|
15/12/2020
11:37 | dplewis1: Yeah off book, no price movement?
|
30/11/2020
19:02 | dplewis1: Nope not a clue, certainly someone was keen to take a few looking at the 100k and 50k blocks. We're long overdue some news.. if it's tomorrow anyone believing in the 1 share trade will be happy
|
27/9/2020
16:49 | dplewis1: ETX gets a mention from Zak and his tea leaves. https://www.share-talk.com/share-talk-bulletin-board-heroes-sunday-special-27th-september-2020/#gs.gpcka2
|
07/7/2020
18:29 | paleje: They transfer to your regular share account, takes a few days though. It costs 20 quid, can't see much benefit in it as the share price often reverts to the placing price with lower costs. 30% is a heck of a discount.
|
04/6/2020
18:14 | paulcon1: DP.....
I agree but my initial reason for investing was the share price was at 2p, the MKt Value was 6-7 million (approx) and investors were taking advantage of Mr Woodford's misery...
At 21.75p (week back) I thought ETX share price was in unchartered waters and needed a contract to justify the share price . Other posters disagreed...
It is very difficult to place a price on potential and Intellectual Property..
That said, ETX, look to have great technology that could have game-changing possibilities, have a strong team and some wealthy investors seem to be very keen to hoover up shares. The more I read (and partially understand) the more impressed I am with their work and vision.
I bought some shares at 17.25p today... The joys of investing!!
GLA and IMHO
|
E-therapeutics share price data is direct from the London Stock Exchange
PLUS1
EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist